Study of the Induction of Anti-Cancer Immunity Effects of Interleukin 12 and Co-Stimulatory Molecules B7-1

姜洁,梁华茂,孔北华,马道新,江森

DOI: https://doi.org/10.3781/j.issn.1000-7431.2004.02.011

2004-01-01

Tumor

Abstract:Objective To study the therapeutic effect and the synergetic mechanism of interleukin 12 (IL-12) and co-stimulatory molecule B7-1(CD80) on rat ovarian cancer model. Methods Retroviral vector pLmIL-12SN or pLmB7-1SN,which encoded mouse IL-12 or B7-1,was used to infect NuTu-19,rat epithelial ovarian cancer cell line,by lipofectin-mediated gene transfer system. Cell lines which could highly express either or both of IL-12 or B7-1,were named NuTu-19/IL-12,NuTu-19/B7-1 or NuTu-19/IL-12-B7-1 accordingly,and NuTu-19/Neo (transfected by vector pLXSN) was used as a control. The intraperitoneal disseminated ovarian cancer animal models were immunized with various mitomycin C-treated gene modified tumor cells. The survival time was observed,and the anti-tumor mechanisms were discussed. Results The splenic lymphocytes proliferation and cytotoxic effect of cytotoxic lymphocytes (CTLs) on syngeneic tumor cells increased significantly in fischer 344 rats immunized by various MMC -treated cytokine modified tumor cells,especially in IL-12 and B7-1 coexpressing group,which also had a prolonged survival time( P 0.05). Conclusion IL-12 and B7-1 gene modified tumor cells can induce anti-tumor immunity through stimulating lymphocytes proliferation and inducing recognition and cytotoxic effects of CTLs on tumor cells. An obvious synergistic effect exists when the two cytokines are combined,and it seems to be a promising therapeutic strategy for ovarian cancer.